U.S. M&A deal activity down 5.7%, private equity activity up 10.1% in February
U.S. M&A news and trends from FactSet Mergers for March 2015.
Does ISS pull the strings in a proxy fight?
Activists and corporate targets seek out the endorsement of ISS, as it may be a deciding factor in close proxy contests.
Steady Improvement Projected for U.S. Homebuilders
Homebuilding analysts are projecting sliding sales trends to reverse in 2015.
Without NOL protections, short-term activism value gains often become long-term losses
Most companies that experienced sufficient net operating losses to deem it necessary to protect the asset’s value could not...
Proxy access wolf packs in sheep's clothing
Proxy access may be much more than another checkbox on the shareholder rights scorecard.
Poison pills and net operating loss assets: protecting the balance sheet or the board of directors?
The overall activism rate against companies with NOL-specific poison pills is similar to the rate for companies that adopt...
2014 Poison Pill Impetus: Why are U.S. companies adopting poison pills?
In 2014, 57 poison pills were adopted by 54 distinct U.S. incorporated companies.
Evaluate portfolio risk with Axioma's macroeconomic model on FactSet
Axioma's macroeconomic model is now available on FactSet.
Public pension funds striving for proxy access may unsettle company boards
New York City Comptroller Scott Stringer's “Boardroom Accountability Project 2015” takes aim at 75 public companies with issues...
Sleeping giant public pension fund could be valuable ally for activists
As activists seek larger, traditionally passive investors as potential allies for activism campaigns, Norges Bank Investment...
FactSet partners with Wall Street Journal to introduce Activism Scorecard
The Scorecard is a ranking of financial advisers and law firms working on or against activist investors’ public campaigns.
Which retailers in the S&P 500 are projected to see the highest and lowest earnings growth for the fourth quarter?
The best way to understand what makes FactSet different is to see it for yourself. We've worked with investment professionals for 40 years, so we understand your workflow and know precisely how to help. Talk to us about your challenges, and we’ll help you design the most effective solutions for your firm with everything you need — and not what you don’t.
The information contained in this article is not investment advice. FactSet does not endorse or recommend any investments and assumes no liability for any consequence relating directly or indirectly to any action or inaction taken based on the information contained in this article.